Public annual accounts

Dr. Sengeleng Jan financials

Name: Dr. Sengeleng Jan financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Dr. Sengeleng Jan, with comparable measures and links to available source documents.

Company overview

Registry number

0898825655

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 27, 2026

Financial evidence

Latest movements for Dr. Sengeleng Jan

2025 versus 2024

Operating line: €135,361
EBITDA: €135,030
Total assets: €457,498
Equity: €435,137

EBITDA margin +99.8% · Equity ratio +95.1%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€135,361	€135,030	€457,498	€435,137	-
202431 Dec 2024	€145,939	€145,675	€524,769	€506,244	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report